Coherus BioSciences, Inc. , a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States.
Coherus Biosciences stock last closed at $1.36, down 2.21% from the previous day, and has decreased 73.66% in one year. It has underperformed other stocks in the Biotechnology industry by 0.66 percentage points. Coherus Biosciences stock is currently +13.33% from its 52-week low of $1.20, and -73.75% from its 52-week high of $5.18.
At the moment, there are 115.21M CHRS shares outstanding. The market cap of CHRS is $156.68M. In the past 24 hours, 755,919 CHRS shares were traded.
How to Buy Coherus Biosciences Stock
Not sure how to invest in Coherus Biosciences stock? Here's how.
Figure out where to buy Coherus Biosciences stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you choose where to buy Coherus Biosciences stock.
Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
Deposit funds into your investment account: Choose your method of payment and add your information.
Evaluate Coherus Biosciences stock: The Coherus Biosciences ticker symbol is CHRS. Is Coherus Biosciences stock a good investment? Should you buy shares of CHRS? How do CHRS's underlying business fundamentals look? Do top analysts think Coherus Biosciences is a good buy? Why has CHRS's stock price moved recently? (Hint: Our stock research website can help you evaluate if CHRS is a good stock to buy).
Make your CHRS trade: Decide if you will purchase CHRS shares at the current market price or use a limit order to buy CHRS shares at a particular price.
Keep tabs on your investment in CHRS: Create a watchlist to key updates about your position in Coherus Biosciences shares.
Step 1: Figure out where to buy Coherus Biosciences stock
You need a brokerage account in order to access the NASDAQ market and buy CHRS stock.
A brokerage account allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
We believe that eToro is the best stock brokerage. Here's why:
Invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to world markets: From Tech to Energy, New York to Hong Kong — you can fill your portfolio with stocks from the world's top exchanges.
Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by signing up for an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for your brokerage account
Now that you've chosen the right brokerage, the next step is to fill out some personal information so you are able to buy CHRS stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Coherus Biosciences stock
Once you have decided on the best place to buy Coherus Biosciences stock, it's absolutely critical to analyze their stock before you invest, so you truly wrap your head around the risk and upside.
Coherus Biosciences Numbers
CHRS Price
$1.36
1w %
1.53%
1y %
-73.66%
5y %
-93.45%
P/E
-3.89x
P/B
-1.86x
P/S
0.51x
PEG
N/A
Revenue
$308.13M
Earnings
-$29.34M
Fore. Rev. Growth
11.73%
Fore. Earn. Growth
N/A
Market Cap
$156.68M
Next Earnings
Nov 4, 2024
Next Dividend
N/A
Coherus Biosciences Due Diligence Checks
WallStreetZen was designed to help part-time investors do more in-depth fundamental analysis in minutes instead of hours.
Last year, CHRS revenue was $308.13M. In the last five year, CHRS's revenue has gone up by 20.65% per year. This was slower than the Biotechnology industry average of 55.92%.
No, Coherus Biosciences doesn't provide an income stream by paying out dividends.
CHRS Social Trading Data
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Make your CHRS trade
There are two primary types of orders:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are usually sufficient.
Limit order: A limit order enables you to buy or sell a stock at a specific price (or better). If you want to make sure you're buying or selling at a particular price limit, place a limit order.
Click the Open button and your broker will execute the order.
If you need additional help with investing in stocks on eToro, click the helpful video below:
How much does it cost to buy one Coherus Biosciences share?
As of Sep 10, 2024, it costs $1.36 to buy one share of Coherus Biosciences stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.68, you can buy 0.5 shares of CHRS.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.